Quality in bariatric surgery: “Does preoperative single-shot cefuroxime have an impact on the wound infection rate after laparoscopic Roux-Y gastric bypass?"

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022421

Enrollment

600

Registered

2020-07-29

Start date

2020-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66 T81.4

Interventions

Group 1: Patients who received a gastric bypass and a preoperative antibiosis Group 2: Patients who received a gastric bypass whitout the administration of preoperative antibiosis

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who have received a laparoscopic gastric bypass (if the indication is in accordance with the guidelines) - Age = 18 years - Signed patients consent

Exclusion criteria

Exclusion criteria: Conversion to the open surgical procedure Patients under the age of 18 years

Design outcomes

Primary

Measure	Time frame
hospitalization rate due to a wound infection	—

Secondary

Measure	Time frame
Postoperative complications 30 days after primary surgery Wound infection 30 days after primary surgery	—

Countries

Germany

Contacts

Public ContactGianluca De Santo

HELIOS Klinikum Berlin-Buch

gianluca.desanto@helios-kliniken.de030/940112782

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026